Author name: zascorporation

The conclusion of CPHI Barcelona signifies not just the end of an event but the dawn of exciting new opportunities for ZAS. This milestone marks the commencement of a journey filled with intensive networking and productivity, solidifying powerful connections with industry innovators. With an expanded global network as a foundation, ZAS is now strategically positioned …

A successful conclusion of CPHI Barcelona & the start of exciting new opportunities! Read More »

ZAS marked a historic milestone by hosting the inaugural Scientific Session at Hotel Radisson Blu Dhaka, focusing on the preventive potential of Lyophilized Bacterial Lysates for Recurrent Respiratory Tract Infections. The event showcased the newly launched Broncho-Vaxom, a revolutionary lyophilized bacterial lysate with a precise 7mg dosage. Attended by distinguished ICU, Respiratory Medicine, Pediatrician, and …

ZAS Revolutionizes Respiratory Health with Groundbreaking Scientific Session. Read More »

In a significant stride towards advancing eye healthcare, Md. Zahidul Islam, the Managing Director of ZAS Pharma Ltd., recently participated in the 14th Annual National Conference of the Bangladesh Glaucoma Society (BGS) held in Vietnam. The event served as a pivotal platform for professionals and experts in the field of ophthalmology to exchange knowledge and …

ZAS Pharma Ltd.’s Managing Director, Md. Zahidul Islam, Spearheads Advancements in Glaucoma Care at the 14th Annual BGS Conference in Vietnam. Read More »